About HEcoPerMed

HEcoPerMed stands for “Healthcare- and pharma-economics in support of the International Consortium for Personalised Medicine – ICPerMed". The project responds to the demand for economic models that evaluate treatments made possible through innovations in personalised medicine. HEcoPerMed also seeks to identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations. HEcoPerMed goes beyond current assessment and payment models in order to serve the need of personalised medicine for more comprehensive cost-effectiveness estimates – incorporating patient and societal perspectives – and for sustainable affordability of cutting-edge health innovations.

What is the aim of HEcoPerMed?

Our project aims to identify the best modelling and payment strategies for personalised medicine to differentiate between promises and reality.

Guidance on health economic modelling

Personalised medicine aims to optimally match patient and treatment by assessing the characteristics of patients related to treatment effectiveness.

Application of best practice health economic modelling in personalised medicine

Develop cost-effectiveness and budget impact models for three case studies by using publicly available input data.

Financing and payment models

Identify funding and reimbursement mechanisms that provide financial incentives for the rapid development and uptake of such innovations.

Benefits and challenges for European health care

Assess the role and relevance of personalised medicine for the future of the European Social Models of Health Care.

Dissemination and communication

Disseminate the obtained results and organise two scientific workshops and a stakeholder conference.

Project partners

The project consortium consists of six partners from five European countries.

Latest News

Project kick-off meeting HEcoPerMed

Group picture

The macro-economic perspective on Personalised Medicine and what it can do for European Health Systems is still an unsolved matter. The HEcoPerMed project is dedicated to this challenge in the context of health economics and policy making. The official kick-off event of this EU Horizon 2020 project took place from 28 to 29 January in Brussels. All partners got together in order to discuss the implementation of the action and to define next steps and public events.

The HEcoPerMed project started on 1st January 2019 under the coordination of AIT Austrian Institute of Technology, Center for Innovation Systems and Policy. Partners also include the AIT Center for Health & Bioresources the German Aerospace Center e.V. (DLR), the Institute for Medical Technology Assessment and the Erasmus University Rotterdam, the Syreon Research Institute, Budapest, and the University of Oxford.

Kick-off Meeting

The official kick-off event of the EU Horizon 2020 project HEcoPerMed (Health Economic Models for Personalised Medicine) will take place from 28 to 29 January in Brussels. At the meeting of the consortium partners the WPs will be presented and further activities will be discussed.

Project launch

Logo_HEcoPerMed

The HEcoPerMed project started on 1.1.2019. The project aims to provide guidance on state-of-the-art health economic modelling, and on financing and payment strategies for personalised medicine in order to distinguish promises from reality. The project consortium consists of the AIT Austrian Institute of Technology, the German Aerospace Center EV, the Institute for Medical Technology Assessment, the Syreon Research Institute and the University of Oxford. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 824997.

Project Information

Project acronym:   HEcoPerMed
Project full title:     Health Economic Models for Personalised Medicine
Starting date:  01.01.2019
Duration:      36 months
Coordinator:         Dr Susanne Giesecke